Loading clinical trials...
Loading clinical trials...
An Exploratory Research of Soluble B7-H3 Expression in Peripheral Blood as a Biomarker to Monitor Therapeutic Effect of Systemic Treatment for Osteosarcoma
Conditions
Interventions
ELISA: enzyme-linked immunosorbent assay
Locations
1
China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Start Date
June 5, 2023
Primary Completion Date
July 1, 2024
Completion Date
December 31, 2024
Last Updated
May 14, 2024
NCT07550023
NCT07462897
NCT06541262
NCT07486401
NCT07479732
NCT07144254
Lead Sponsor
Peking University People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions